How to Buy Lumos Pharma Stock
Lumos Pharma Inc
Lumos Pharma, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases.
Lumos Pharma stock last closed at $2.62, up 3.97% from the previous day, and has decreased 19.63% in one year. It has overperformed other stocks in the Biotechnology industry by 0.07 percentage points. Lumos Pharma stock is currently +8.71% from its 52-week low of $2.41, and -42.42% from its 52-week high of $4.55.
As of Apr 18, 2024, there are 8.11M shares of LUMO outstanding. The market capitalization of LUMO is $21.24M. In the past 24 hours, 12,386 LUMO shares were traded.
How to Buy Lumos Pharma Stock
Wondering how to invest in Lumos Pharma stock? Here's how.
- Figure out where to buy Lumos Pharma stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Lumos Pharma stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your method of payment and add your information.
- Evaluate Lumos Pharma stock: The Lumos Pharma ticker symbol is LUMO. Is Lumos Pharma stock a good investment? Should you buy shares of LUMO? How do LUMO's underlying business fundamentals look? Do top analysts think Lumos Pharma is a good buy? Why has LUMO's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if LUMO is a good stock to buy).
- Execute your LUMO buy order: Decide if you will purchase LUMO shares at the current market price or use a limit order to purchase LUMO shares at a given price.
- Get the latest news on your LUMO investment: Create a watchlist to the latest updates on your position in Lumos Pharma stock.
Step 1: Figure out where to buy Lumos Pharma stock
You will need an online brokerage account in order to access the NASDAQ market and buy LUMO stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Real Estate, New York to London — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you can invest in LUMO today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new trading account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have finished signing up on our top ranked stock market app, you can securely and quickly fund your account:
Watch the walkthrough below to see the process of depositing funds into your investment account.
Step 4: Evaluate Lumos Pharma stock
After you have figured out the best place to buy Lumos Pharma stock, it's absolutely critical to analyze their stock prior to investing, so you can wrap your head around the risk and upside.
Lumos Pharma shares quick numbers
Fundamentals of Lumos Pharma
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on LUMO's stock page.
Is LUMO stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge LUMO's true value.
Using relative valuations methods:
- LUMO may be undervalued based on its P/B ratio of 0.78x, relative to Biotechnology industry P/B ratio of 5.76x
You can do additional valuation analysis on LUMO's stock here.
LUMO Financials at a glance
Positive Financial Indicators:
- LUMO has $36.08M in cash and short term investments. This is enough to cover its annual cash burn of $31.10M.
- LUMO has cash burn of 31095000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the LUMO balance sheet.
- There are more short-term assets than long-term liabilities on the LUMO balance sheet.
Negative Financial Indicators:
- LUMO has a relatively high debt to equity ratio of 0.49.
- LUMO profit margin has gone up by 3.8 percentage points in the past year, but the company is still unprofitable.
- Total LUMO debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy Lumos Pharma stock
Out of 2 Wall Street analysts who monitor LUMO, the consensus analyst rating on Lumos Pharma is a Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Lumos Pharma stock forecast page.
LUMO Trading Indicators
LUMO Performance Metrics
Last year, LUMO revenue was $2.05M. During the last 5 year, LUMO's revenue has grown by -30.31% per year. This was slower than the Biotechnology industry average of 28.98%.
Learn more about LUMO's earnings and revenue performance here.
What are LUMO executives and large shareholders up to?
Over the last 12 months, insiders at LUMO have bought more shares than they have sold.
John C. McKew, Chief Scientific Officer of LUMO, was the latest LUMO insider to sell. They sold $6,143.85 worth of LUMO shares on Apr 3, 2024.
Dig into more about who owns LUMO shares here.
Does LUMO provide a stable income stream?
No, Lumos Pharma doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your LUMO buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and eToro will execute your order.
If you require more info about buying stocks on eToro, click the how to video below:
Step 6: Get the latest news on your LUMO investment
Now that you own some LUMO stock, you'll want to stay up-to-date on your new company.
Start a watchlist to get alerted to the latest events about your LUMO stock.
LUMO Feed
How to Buy Stock in Lumos Pharma
To summarize, here are the 6 steps to buy Lumos Pharma stock:
- Figure out where to buy Lumos Pharma stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Evaluate Lumos Pharma stock
- Execute your LUMO buy order
- Get the latest news on your LUMO investment
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Lumos Pharma, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.